HIGHLIGHTS
- who: Klaske Vliegenthart-Jongbloed et al. from the Department of Medical Microbiology and Infectious Diseases, Erasmus MC, Rotterdam, the Netherlands have published the research: REVIEW Open Access, in the Journal: (JOURNAL)
- what: Based on the example of Tanzania, we discussed the lack of microbiological, pharmacological and clinical evidence for non-recommended antibiotic fixed drug combinations (FDC-AB) as well as the concerns of appropriate dosing, safety and risk for antimicrobial resistance (AMR).
SUMMARY
Fixed-dose combinations (FDC) are medicine formulations that combine two or more active ingredients in fixed ratios in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.